These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1082 related articles for article (PubMed ID: 14678992)

  • 41. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
    Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.
    Lai WL; Hung WY; Wong LL; Zhou Y; Leong VY; Lee JM; Ng IO; Jin DY; Ching YP
    Hepatology; 2012 Nov; 56(5):1770-81. PubMed ID: 22610972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
    Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
    Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
    Miyazaki H; Watabe T; Kitamura T; Miyazono K
    Oncogene; 2004 Dec; 23(58):9326-35. PubMed ID: 15531927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells.
    Duan L; Yao J; Wu X; Fan M
    Biol Cell; 2006 Aug; 98(8):479-90. PubMed ID: 16608439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.
    Yuan ZM; Huang Y; Whang Y; Sawyers C; Weichselbaum R; Kharbanda S; Kufe D
    Nature; 1996 Jul; 382(6588):272-4. PubMed ID: 8717045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Jung KH; Kim JK; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Park WS; Lee JY; Nam SW
    J Cell Biochem; 2010 Jun; 110(3):687-96. PubMed ID: 20512928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis.
    Yim HW; Jong HS; Kim TY; Choi HH; Kim SG; Song SH; Kim J; Ko SG; Lee JW; Kim TY; Bang YJ
    Cancer Res; 2005 Mar; 65(5):1952-60. PubMed ID: 15753395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
    Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
    Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of Notch1 on cell cycle, apoptosis and migration of laryngeal squamous cell carninoma cell line Hep-2].
    Jiao J; Li S
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):104-9. PubMed ID: 22780927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
    Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X
    J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of p21(WAF1/Cip1), CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition.
    Zauberman A; Oren M; Zipori D
    Oncogene; 1997 Oct; 15(14):1705-11. PubMed ID: 9349504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner.
    Bae KM; Wang H; Jiang G; Chen MG; Lu L; Xiao L
    Cancer Res; 2007 Jul; 67(13):6053-63. PubMed ID: 17616661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.
    Zhu B; Sun L; Luo W; Li M; Coy DH; Yu L; Yu W
    Oncotarget; 2017 Apr; 8(14):23289-23302. PubMed ID: 28423575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
    Senturk S; Mumcuoglu M; Gursoy-Yuzugullu O; Cingoz B; Akcali KC; Ozturk M
    Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.